Target intelligence / Profile preview

Dietary triacylglycerols and cholesterol esters (TAG and CE)

Target
TAG and CE
Molecular classification
Other (Lipid substrate)
01

Overview

Dietary triacylglycerols and cholesterol esters are the predominant forms of fat consumed in the human diet, serving as vital energy sources and precursors for cellular components (StatPearls, 2023). In the gastrointestinal tract, these lipids are emulsified by bile salts and hydrolyzed by enzymes such as pancreatic lipase and cholesterol esterase into smaller molecules like fatty acids and free cholesterol for absorption (PubMed, 2021). This absorption process is a key physiological step, but when excessive, it leads to metabolic disorders including obesity and hyperlipidemia, which are major risk factors for cardiovascular disease (NIH, 2022). While these lipids are not therapeutic targets in the traditional sense of being proteins, they are the substrates for enzymes and transporters that are targeted by drugs. For instance, orlistat inhibits the lipases required for triacylglycerol breakdown, while ezetimibe targets the NPC1L1 transporter to reduce cholesterol absorption (StatPearls, 2023).

Other names
Dietary fatsIntestinal lipidsNeutral lipidsExogenous lipidsLuminal triacylglycerols and cholesterol esters
02

Mechanism of action

Inhibition of gastrointestinal lipases (e.g., pancreatic lipase) to prevent triacylglycerol hydrolysis, or inhibition of sterol transporters (e.g., NPC1L1) to prevent cholesterol absorption (StatPearls, 2023).

03

Biological functions

Energy storageMembrane synthesisSignaling molecule precursorOther (Nutrient absorption)
04

Disease associations

ObesityHyperlipidemiaCardiovascular diseaseAtherosclerosisMetabolic syndrome
05

Safety considerations

Steatorrhea (oily stools)Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distressFlatulence with discharge
06

Interacting drugs

Orlistat

1 more in the full profile.

07

Biomarkers

Serum triglyceridesLDL cholesterolFecal fat contentTotal cholesterol

Beyond the preview

Go deeper on Dietary triacylglycerols and cholesterol esters (TAG and CE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary triacylglycerols and cholesterol esters (TAG and CE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call